trial · primary record
Autologous HLA-A*02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells
Acute Myeloid Leukemia
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 9 |
| Primary completion | 2030-07-19 |
| Primary endpoint | Incidence of treatment related grade 3 or higher adverse events |
| Registry ID | NCT07645469 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:05.619Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07645469
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.